Blueprint Medicines, a Sanofi company, today announced updated data reinforcing the clinical efficacy and safety of long-term AYVAKIT® (avapritinib) use across the spectrum of systemic mastocytosis ...
Top Speed on MSN
10 SUVs and crossovers that still feature a six-cylinder engine
In a world cluttered by emission regulations and the advent of electric vehicles, these 12 SUVs still rock a six-cylinder ...
The advanced M3000/M4000 series of PAC Controllers from Weidmuller USA integrates the functionality of a PLC and a PC with a control and edge system – in one device. The reliability and security of ...
Follow-up data from CARTITUDE-4 show at least 80 percent of as-treated standard-risk patients remained progression and treatment-free following a single ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback